Masaru Matsuda

CIK 1798679 · See Remarks · last filed 2026-05-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.11M

Companies

2

Total Filings

34

Lifetime Open-Market Net

-$3.06M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARQT See Remarks 127,573 $24.38 $3.11M -$3.06M 28 2026-05-06
HALOZYME THERAPEUTICS, INC. (HTI) Delisted SVP, General Counsel 20,049 $0 6 2021-09-07

Recent Filings · Page 2 of 4

34 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-03-04 ARQT Mixed +30,737 -$42.5K EDGAR
2025-02-04 ARQT Sell (S) −8,338 -$105.9K EDGAR
2024-12-03 ARQT Buy (P) +5,657 $18.5K EDGAR
2024-11-19 ARQT Mixed +3,100 -$17.2K EDGAR
2024-11-05 ARQT Sell (S) −5,015 -$43.6K EDGAR
2024-08-05 ARQT Sell (S) −5,220 -$47.1K EDGAR
2024-05-29 ARQT Mixed +3,100 -$16.0K EDGAR
2024-05-03 ARQT Sell (S) −5,016 -$43.8K EDGAR
2024-03-06 ARQT Sell (S) −3,760 -$41.8K EDGAR
2024-02-15 ARQT Mixed +119,550 $0 EDGAR
Showing 1120 of 34
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.